The DermaKIDS study is an open-label, single-arm interventional study designed to evaluate the safety and efficacy of a probiotic-containing cream in children with dry skin. Approximately 40 children aged from newborn to 7 years will be enrolled at two study sites in Portugal. Participants will apply the study cream twice daily for a period of four weeks under normal home-use conditions. The primary efficacy endpoint is the change in Overall Dry Skin Score (ODS) from baseline to the end of the study. Safety and efficacy will be assessed through investigator evaluations combined with weekly parent-reported diaries and standardized photographs.
Eligibility
Sex
ALL
Min age
0 Months
Max age
7 Years
Healthy volunteers
No
Inclusion Criteria:
1. Newborn - 7 years.
2. ODS ≥ 2 in the target area.
3. Parent/guardian able to comply with weekly diaries/photos and visits.
4. Signed ICF by parent/legal guardian; assent as required.
Exclusion Criteria:
1. Topical medicated treatments on target area within 2 weeks.
2. Active skin infection or severe eczema flare at target site.
3. Known allergy to product components.
4. Participation in another study within 30 days.
5. Any condition judged by investigator to preclude participation.
Primary outcome measure(s)
Primary objective — From Baseline to Week 4 Evaluate change in Overall Dry Skin Score (ODS) from baseline to Week 4 after regular application (twice daily, every day) of Probiotic skin ointment (Study Product) versus baseline.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
